These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 6612136)

  • 41. [Classification and symptomatology of migraine].
    Soyka D
    Fortschr Med; 1984 Mar; 102(12):323-7. PubMed ID: 6714905
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Migraine in the elderly: a comparison with migraine in young adults.
    Martins KM; Bordini CA; Bigal ME; Speciali JG
    Headache; 2006 Feb; 46(2):312-6. PubMed ID: 16492241
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The premonitory symptoms (prodrome): a tertiary care study of 893 migraineurs.
    Kelman L
    Headache; 2004 Oct; 44(9):865-72. PubMed ID: 15447695
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diagnosing and managing migraine headache.
    Mueller LL
    J Am Osteopath Assoc; 2007 Nov; 107(10 Suppl 6):ES10-6. PubMed ID: 17986672
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Acute hypotensive effect of a central dopaminergic agonist, piribedil, administered intravenously in the normotensive human].
    Ziegler M; Georgiadis G; Elghozi JL
    Arch Mal Coeur Vaiss; 1984 Oct; 77(11):1186-90. PubMed ID: 6441537
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Stimulation of somatotropin hormone by piribedil, a dopaminergic agonist, in endogenous depression. Preliminary study].
    Guillaume R; Charles G; Mesters P; Schittecatte M; Wilmotte J
    Acta Psychiatr Belg; 1988; 88(2):153-61. PubMed ID: 2905110
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Piribedil test in migraine: neuroendocrinological aspects.
    Bussone G; Frediani F; Lamperti E; LaMantia L; Vescovi A; Peccarisi C; Boiardi A
    Headache; 1986 Oct; 26(9):482-5. PubMed ID: 3781836
    [No Abstract]   [Full Text] [Related]  

  • 48. [The piribedil test in the diagnosis of migraine].
    Dano P
    Presse Med; 1987 Apr; 16(13):634. PubMed ID: 2952980
    [No Abstract]   [Full Text] [Related]  

  • 49. Does the piribedil test permit predicting the efficacy of domperidone, a dopaminergic antagonist, in the treatment of migraine?
    Montastruc JL; David J; Rascol A
    Headache; 1985 Sep; 25(6):332-3. PubMed ID: 4055368
    [No Abstract]   [Full Text] [Related]  

  • 50. [Chronic paroxysmal migraine: a new entity or a transient form? Apropos of 3 new clinical cases].
    Centonze V; Macinagrossa G; Magrone D; Attolini E; Vino M; Tesauro P; Campanozzi F; Albano O
    Minerva Med; 1987 Jul; 78(14):977-9. PubMed ID: 3601171
    [No Abstract]   [Full Text] [Related]  

  • 51. Cluster headache syndrome and migrain. Ophthalmological support for a two-entity theory.
    Horven I; Sjaastad O
    Acta Ophthalmol (Copenh); 1977 Feb; 55(1):35-51. PubMed ID: 576545
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Headache patients: different responses induced by naloxone during work-test.
    Steardo L; Barone P; di Stasio E; Bonuso S
    Cephalalgia; 1982 Sep; 2(3):151-6. PubMed ID: 7151148
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Migraine and tension headache: is there a physiological difference?
    Anderson CD; Franks RD
    Headache; 1981 Mar; 21(2):63-71. PubMed ID: 7239903
    [No Abstract]   [Full Text] [Related]  

  • 54. Blood pressure and risk of headache: a prospective study of 22 685 adults in Norway.
    Hagen K; Stovner LJ; Vatten L; Holmen J; Zwart JA; Bovim G
    J Neurol Neurosurg Psychiatry; 2002 Apr; 72(4):463-6. PubMed ID: 11909904
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Piribedil, dopaminergic agonist and the cerebral neurovascular syndrom of the aging man (author's transl)].
    Babeau P; Pras P; Serizet A
    Sem Hop; 1980 Jan 18-25; 56(3-4):188-92. PubMed ID: 6244655
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Controlled telethermographic study of the peripheral vasoactivity of oral piribedil.
    Huys J; Brems H; de Schrijver A
    Curr Med Res Opin; 1977; 4(9):654-9. PubMed ID: 338254
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of reserpine injections in migrainous and normal control subjects, with estimations of urinary 5-hydroxyindoleacetic acid.
    Tandon RN; Sur BK; Nath K
    Neurology; 1969 Nov; 19(11):1073-9. PubMed ID: 5388075
    [No Abstract]   [Full Text] [Related]  

  • 58. Headache characteristics in patients after migrainous stroke.
    Allaryari P; McAbee GN; Mueller L; White R
    Neurology; 2002 Feb; 58(4):668-9; author reply 669. PubMed ID: 11865161
    [No Abstract]   [Full Text] [Related]  

  • 59. Perspectives in migraine.
    Hall JA
    West Indian Med J; 1971 Dec; 20(4):296-9. PubMed ID: 5173457
    [No Abstract]   [Full Text] [Related]  

  • 60. Psychogenic basilar migraine: report of four cases.
    Sanchez-Villasenor F; Devinsky O; Hainline B; Weinreb H; Luciano D; Vazquez B
    Neurology; 1995 Jul; 45(7):1291-4. PubMed ID: 7617184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.